Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEQUAR - SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction - a Prospective Randomized Study

NCT04295148 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT04295148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04295148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEQUAR - SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction - a Prospective Randomized Study
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Recruiting
Start date
February 10, 2020
Completion date
May 31, 2035
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament injuries, anterior cruciate ligament rupture, anterior cruciate ligament tear